224. Purpura nephritis Clinical trials / Disease details


Clinical trials : 13 Drugs : 42 - (DrugBank : 20) / Drug target genes : 15 - Drug target pathways : 57

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02878018
(ClinicalTrials.gov)
September 201617/8/2016Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura NephritisCohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura NephritisHenoch-Schonlein Purpura NephritisDrug: Qi-Ji Shen-Kang formula; Zhu-Bai formula; Yu-Shen formula;Drug: angiotensin-converting enzyme (ACE) inhibitor; adrenergic receptor binder (ARB); adrenal cortical hormone; Tripterygium wilfordii polyglycosidium; immunosuppressantLiaoning University of Traditional Chinese MedicineFirst Hospital of China Medical University;Shengjing HospitalActive, not recruiting5 Years18 YearsAll600China
2NCT02532777
(ClinicalTrials.gov)
August 201520/8/2015The Research of Standard Diagnosis and Treatment for HSPN in ChildrenThe Research of Standard Diagnosis and Treatment for Henoch-Schonlein Purpura Nephritis in ChildrenHenoch-Schoenlein Purpura NephritisDrug: Prednisone;Drug: Cyclophosphamide(CTX);Drug: Mycophenolate mofetil(MMF);Drug: Leflunomide(LEF);Drug: Angiotensin-converting enzyme inhibitor(ACEI);Drug: MethylprednisoloneNanjing Children's HospitalNULLRecruiting2 Years16 YearsAll100Phase 2China